Experimental models reveal that loss or reduction of ACE2 worsens lung injury after viral infection, likely due to unchecked angiotensin II activity via angiotensin II type 1 receptor (AT1R), leading to inflammation, vasoconstriction and fibrosis (58, 59). Here, AGTR1 is linked to viral infectious disease.